iiinova — where your digital self keeps evolving

UCL Business @uclb.bsky.social · 25/11/2025

NICE has today announced that AUCATZYL® can be made available on the NHS to eligible patients with acute lymphoblastic leukaemia! 🥳 This huge step forward means the pioneering immunotherapy treatment, developed by UCLB spinout venture Autolus Therapeutics, will be available 1/

110

UCL Business @uclb.bsky.social · 10/11/2025

Europe wants to lead the way for ease and fairness of IP commercialisation. Under the EU Startup and Scaleup Strategy, the European Commission is creating a blueprint for licensing, revenue-sharing, & equity participation for academic institutions & inventors. Our CEO, Anne Lane, contributed 1/

eu flags with the caption below: Anne Lane contributes to EU blueprint workshop for licensing and spinoff creation

120

UCL Business @uclb.bsky.social · 07/11/2025

The AI revolution in life sciences is already here – and it’s changing the sector. Our CEO, Anne Lane has written about university spinouts, AI and investment in the UK for One Nucleus, sharing her excitement for the potential of the sector here in Britain... 1/

120

UCL Business @uclb.bsky.social · 04/11/2025

Thank you to Professor Stefan Howorka for his insightful contributions at our recent IO Converse session! Professor Howorka, a pioneer of nanopore technology, shared that his attitude towards research has shifted following his journey to commercialisation in a discussion with Barny Cox. 1/

110

UCL Business @uclb.bsky.social · 28/10/2025

A groundbreaking multiple sclerosis trial, that could offer hope to millions, has begun using Autolus Therapeutics CAR T-cell therapy platform. Patients with progressive multiple sclerosis (PMS) are receiving 'obe-cel' treatment in this phase 1 trial at UCL Hospitals NHS Foundation Trust. 1/

Woman in hospital bed receives treatment from a nurse, while she talks to a doctor at the foot of her bed. Family members in the room look on hopefully

111

UCL Business @uclb.bsky.social · 21/10/2025

UCL and its spinouts are leaders for equity investment, according to the Beauhurst report! 🏆 The analytics company ranked UCL fourth for the number of equity deals secured by spinouts in 2024, and second for equity deal volume.

100

UCL Business @uclb.bsky.social · 17/10/2025

How can universities support founders of social ventures? 🤝 This was the topic of discussion at the Bates Wells and London Social Venture (LSV) event on 9th October... Analia Lemmo, UCLB Senior Business Manager, joined the panel to share how ideas can be turned into impact.

110

UCL Business @uclb.bsky.social · 30/09/2025

What if the next global innovation supercluster wasn’t in Boston or Silicon Valley - but in Euston? 🌍 Our CEO Anne Lane joined leaders from Camden Council, Lendlease, UCL partner hospitals and more for the 'Unlocking Inclusive Growth Through Innovation' breakfast at #Lab25 in Liverpool yesterday.

Woman in purple jacket with blonde hair talks enthusiastically, sat at a table with others over coffee.

120

UCL Business @uclb.bsky.social · 29/09/2025

🚨IO Converse is back! Don't miss your chance to hear from @ucl.ac.uk’s Professor Stefan Howorka about his journey from academic research to real-world impact. Prof. Howorka will discuss his experience working with Oxford Nanopore Technologies, an Oxford spinout, including his pivotal role... 1/

110

UCL Business @uclb.bsky.social · 23/09/2025

Thrilled to announce two @ucl.ac.uk researchers have been awarded Proof of Concept funding by @ukri.org. Max Besenhard's smart chromatography for sustainable drug analysis and purification has been recognised, as has Youngjun Cho's accessible journey planner for disabled people, AI Mapper+. 1/3

110

UCL Business @uclb.bsky.social · 19/09/2025

The IO Inspire Autumn Programme begins next month! ⌛ IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research. Find out more and register for the programme here: www.eventbrite.co.uk/e/io-inspire...

010

Reposted by UCL Business

nickchodgson.bsky.social @nickchodgson.bsky.social · 16/09/2025

Good news! Google has said it will invest £5bn in the UK in the next two years to help meet growing demand for artificial intelligence services, in a boost for the government, @theguardian.com reports. Coincides with US president Donald Trump's visit @uclb.bsky.social @profgeraintrees.bsky.social

theguardian.com

Google announces £5bn AI investment in UK before Trump visit

Rachel Reeves says move is a ‘vote of confidence’ in British economy as she prepares to open firm’s first UK datacentre

131

Reposted by UCL Business

UCL News @uclnews.bsky.social · 14/09/2025

Could these companies be turning their backs at precisely the wrong moment?, asks @profgeraintrees.bsky.social after US firm Merck put the brakes on a £1 billion London research centre & AstraZeneca said it would pause a £200m investment to expand its research and development arm in Cambridge

thetimes.com

Why Merck and AstraZeneca may regret turning their back on Britain

The pair may have gone cold on the UK but start-ups and university spinouts here are using AI to revolutionise drug discovery

0179

UCL Business @uclb.bsky.social · 12/09/2025

This Stand Up To Cancer Day, we highlight the latest groundbreaking work in oncology by UCLB’s spinouts, licences and partnerships. You can read our Stand Up To Cancer Day news story here: www.uclb.com/2025/09/12/s...

010

Reposted by UCL Business

UCL Faculty of Brain Sciences @uclbrainscience.bsky.social · 08/09/2025

We're proud to be training the future leaders in dementia research! 🧠 💪 Read the story of Dr Daniel Andrés Jiménez, a @uclqsion.bsky.social MSc Dementia graduate who went on to advise the Chilean Ministry of Health on dementia: buff.ly/Ek6GbE8 #UCLDementia #WorldAlzheimersDay

Reads: “The Dementia course gave me a comprehensive view of dementia research at a crucial moment in my early research career. There are many research approaches and methods, and the course helped me understand which ones suited me best and how to kick off my career as a researcher.”

032

UCL Business @uclb.bsky.social · 05/09/2025

IO Inspire is a free weekly lunchtime programme for UCL academics looking to explore the commercial potential of their research. The Autumn intake will run from 𝟴𝘁𝗵 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 – 𝟯𝗿𝗱 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿. Find out more about the programme and how to register here: www.uclb.com/events/io-in...

010

UCL Business @uclb.bsky.social · 28/08/2025

A clinical trial conducted by UCL has shown for the first time how a commercially available gene expression test can accurately predict which patients with prostate cancer will benefit from chemotherapy with docetaxel. Find out about UCLB's involvement here: www.uclb.com/2025/08/28/g...